Abstract
Oncogenic transformation is the result of a complex process that involves multiple steps of genetic and cellular alterations, most notably the activation of oncogenes and the inactivation of tumor suppressor genes. Great advances have been made in identifying genetic alterations associated with various human cancers in recent years. The discovery of signaling cross-talk between KRAS and Hedgehog signaling, the two universally dysregulated pathways in pancreatic cancer, provides new insights into understanding the mechanism of pancreatic tumorigenesis and potential novel therapeutic strategy for treating this deadly disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguirre AJ et al (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17(24):3112
Alberts SR (2008) KRAS inhibitors and pancreatic cancer. In: Lowy AM, Leach SD, Philip PA (eds) Pancreatic cancer. Springer, New York, pp 601–607
Almoguera C et al (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53(4):549
Alpert S, Hanahan D, Teitelman G (1988) Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53(2):295
Barbie DA et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462(7269):108
Bardeesy N, DePinho RA (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2(12):897
Berman DM et al (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425(6960):846
Biankin AV et al (2002) DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol 20(23):4531
Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49(17):4682
Caldas C et al (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8(1):27
Caldas C et al (1994) Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54(13):3568
Campbell PM et al (2008) Ras-driven transformation of human nestin-positive pancreatic epithelial cells. Meth Enzymol 439:451
Chen JK et al (2002) Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16(21):2743
Cohen SJ et al (2003) Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma. J Clin Oncol 21(7):1301
Cooper MK et al (1998) Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280(5369):1603
Cubilla AL, Fitzgerald PJ (1976) Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 36(7 PT 2):2690
Dolma S et al (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3(3):285
Feldmann G et al (2007) Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67(5):2187
Feldmann G et al (2008) Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 57(10):1420
Furukawa T et al (1996) Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 148(6):1763
Gisselsson D et al (2001) Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 98(22):12683
Gorunova L et al (1998) Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23(2):81
Guo W et al (2008) Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota. Cancer Res 68(18):7403
Hahn SA et al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271(5247):350
Hall PA, Lemoine NR (1992) Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J Pathol 166(2):97
Harada T et al (2002) Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. Cancer Res 62(3):835
Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605
Hingorani SR et al (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4(6):437
Hingorani SR et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469
Hruban RH et al (2000) Progression model for pancreatic cancer. Clin Cancer Res 6(8):2969
Ingham PW, McMahon AP (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15(23):3059
James G, Goldstein JL, Brown MS (1996) Resistance of K-RasBV12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc Natl Acad Sci U S A 93(9):4454
James GL et al (1993) Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260(5116):1937
Jhappan C et al (1990) TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61(6):1137
Ji Z et al (2009) Chemical genetic screening of KRAS-based synthetic lethal inhibitors for pancreatic cancer. Front Biosci 14:2904
Ji Z et al (2007) Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J Biol Chem 282(19):14048
Jones S et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897):1801
Kaelin WG Jr (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer 5(9):689
Kayed H et al (2004) Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer. Int J Cancer 110(5):668
Klimstra DS, Longnecker DS (1994) K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 145(6):1547
Kohl NE et al (1993) Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260(5116):1934
Kohl NE et al (1995) Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nat Med 1(8):792
Lum L, Beachy PA (2004) The Hedgehog response network: sensors, switches, and routers. Science 304(5678):1755
Luo J et al (2009) A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137(5):835
Luttges J et al (2001) Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158(5):1677
Luttges J et al (1999) The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer 85(8):1703
Meszoely IM et al (2001) Developmental aspects of early pancreatic cancer. Cancer J 7(4):242
Morton JP et al (2007) Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A 104(12):5103
Moskaluk CA, Hruban RH, Kern SE (1997) p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 57(11):2140
Murray NR et al (2004) Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol 164(6):797
Nolan-Stevaux O et al (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23(1):24
Ouyang H et al (2000) Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype. Am J Pathol 157(5):1623
Park SW et al (2008) Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology 134(7):2080
di Magliano Pasca M et al (2006) Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 20(22):3161
Peukert S, Miller-Moslin K (2010) Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics. ChemMedChem 5(4):500
Pour PM, Pandey KK, Batra SK (2003) What is the origin of pancreatic adenocarcinoma? Mol Cancer 2(1):13
Pour PM, Schmied BM (1999) One thousand faces of Langerhans islets. Int J Pancreatol 25(3):181
Qian J et al (2005) In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res 65(12):5045
Rejiba S et al (2007) K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment. Cancer Sci 98(7):1128
Rozenblum E et al (1997) Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57(9):1731
Rudin CM et al (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361(12):1173
Scales SJ, de Sauvage FJ (2009) Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 30(6):303
Schmied BM et al (2001) Transdifferentiation of human islet cells in a long-term culture. Pancreas 23(2):157
Schnidar H et al (2009) Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res 69(4):1284
Scholl C et al (2009) Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 137(5):821
Scotti ML et al (2010) Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res 70(5):2064
Sebti SM, Adjei AA (2004) Farnesyltransferase inhibitors. Semin Oncol 31(1 Suppl 1):28
Seto M et al (2009) Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer. Mol Carcinog 48(8):703
Stecca B et al (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci U S A 104(14):5895
Suehara N et al (1997) Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res 3(6):993
Tada M et al (1996) Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110(1):227
Tascilar M et al (2001) The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res 7(12):4115
Thayer SP et al (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425(6960):851
Tremblay MR et al (2008) Semisynthetic cyclopamine analogues as potent and orally bioavailable hedgehog pathway antagonists. J Med Chem 51(21):6646
Von Hoff DD et al (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361(12):1164
Wang HL et al (2010) KRAS mutation testing in human cancers: the pathologist’s role in the era of personalized medicine. Adv Anat Pathol 17(1):23
Whyte DB et al (1997) K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem 272(22):14459
Wilentz RE et al (1998) Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 58(20):4740
Wilentz RE et al (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60(7):2002
Xie J et al (2001) A role of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci U S A 98(16):9255
Yagoda N et al (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447(7146):864
Yamano M et al (2000) Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 156(6):2123
Yauch RL et al (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326(5952):572
Yuan S et al (1996) Transdifferentiation of human islets to pancreatic ductal cells in collagen matrix culture. Differentiation 61(1):67
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cheng, X. (2011). Signaling Cross-Talk of Oncogenic KRAS and Hedgehog Pathways in Pancreatic Cancer. In: Xie, J. (eds) Hedgehog signaling activation in human cancer and its clinical implications. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-8435-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8435-7_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-8434-0
Online ISBN: 978-1-4419-8435-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)